Lectenz® Bio participates in NIH Commercialization Accelerator Program

The Lectenz® Bio participated in the 2015-2016 Advanced Commercialization Track in the NIH Commercialization Accelerator Program (CAP).

The NIH CAP is designed to help HHS/NIH SBIR/STTR Phase II awardees at different levels of commercialization experience and expertise. Whether an emerging or a seasoned company, the goal of the program is to tackle the complex business challenges that are faced when bringing a product to market.